| BN | 6.22% | 56.61 | +0.43% | 187,838 | |
| FNV | 4.72% | 355.08 | +3.09% | 31,079 | |
| MCK | 4.47% | 872.32 | +0.80% | 7,625 | |
| 005930 | 4.22% | 178,400 | -5.91% | 82,219 | |
Novartis AG ADR | - | 4.03% | - | - | 41,175 |
| UNP | 4.03% | 243.12 | +0.21% | 23,923 | |
| MSFT | 3.92% | 369.37 | -0.22% | 10,241 | |
AstraZeneca PLC ADR | - | 3.87% | - | - | 61,267 |
Heineken NV ADR | - | 3.77% | - | - | 122,622 |
Fiserv Inc | - | 3.50% | - | - | 38,567 |
Advisors Series Trust -Scharf ETF is an open-end equity mutual fund launched by Advisors Series Trust. The fund is managed by Scharf Investments, LLC. It invests in public equity markets of global region. It invests in stocks of companies operating across diversified sectors. It invests in growth at reasonable price stocks of companies across diversified market capitalization. The fund employs fundamental and quantitative analysis with bottom-up stock picking approach to create its portfolio. The fund seeks to benchmark the performance of its portfolio against the S&P 500 Index and the Russell 1000 Value Total Return Index. It employs proprietary research to create its portfolio. Advisors Series Trust - Scharf Fund was formed on December 30, 2011 and is domiciled in the United States.